Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study.

Ketamine abuse has been shown to have a deleterious impact on brain function. However, the precise mechanisms of ketamine dependence-induced pathological change remain poorly understood. Although there is evidence for white matter changes in drug abuse, the presence of white matter abnormalities in chronic ketamine users has not been studied. White matter volumes were measured using in vivo diffusion tensor magnetic resonance imaging data in 41 ketamine-dependent subjects and 44 drug-free healthy volunteers. White matter changes associated with chronic ketamine use were found in bilateral frontal and left temporoparietal cortices. There was also evidence that frontal white matter fractional anisotropy correlated with the severity of drug use (as measured by estimated total ketamine consumption). We provide direct evidence for dose-dependent abnormalities of white matter in bilateral frontal and left temporoparietal regions following chronic ketamine use. The findings suggest a microstructural basis for the changes in cognition and experience observed with prolonged ketamine use. Moreover, the similarities of these changes to those observed in chronic schizophrenia have implications for the glutamate model of this illness.

[1]  Timothy Edward John Behrens,et al.  Training induces changes in white matter architecture , 2009, Nature Neuroscience.

[2]  Jie Shi,et al.  Recent trends in drug abuse in China , 2006, Acta Pharmacologica Sinica.

[3]  Christopher P Hess,et al.  Update on diffusion tensor imaging in Alzheimer's disease. , 2009, Magnetic resonance imaging clinics of North America.

[4]  Hideo Tsukada,et al.  Chronic NMDA Antagonism Impairs Working Memory, Decreases Extracellular Dopamine, and Increases D1 Receptor Binding in Prefrontal Cortex of Conscious Monkeys , 2005, Neuropsychopharmacology.

[5]  Stefan Gazdzinski,et al.  MRSI and DTI: a multimodal approach for improved detection of white matter abnormalities in alcohol and nicotine dependence , 2009, NMR in biomedicine.

[6]  Mark Slifstein,et al.  Altered prefrontal dopaminergic function in chronic recreational ketamine users. , 2005, The American journal of psychiatry.

[7]  Clare E. Mackay,et al.  Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statistics , 2008, NeuroImage.

[8]  A. Lua,et al.  Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. , 2003, Forensic science international.

[9]  Linda Chang,et al.  Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users , 2009, Psychiatry Research: Neuroimaging.

[10]  L. Hoffer,et al.  Dinosaur Girls, Candy Girls, and Trinity: Voices of Taiwanese Club Drug Users , 2008, Journal of ethnicity in substance abuse.

[11]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[12]  A. Belger,et al.  Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. , 2005, Archives of general psychiatry.

[13]  A. Winstock,et al.  Ketamine : from medicine to misuse. , 2006, CNS drugs.

[14]  Khader M Hasan,et al.  Reduced Anterior Corpus Callosum White Matter Integrity is Related to Increased Impulsivity and Reduced Discriminability in Cocaine-Dependent Subjects: Diffusion Tensor Imaging , 2005, Neuropsychopharmacology.

[15]  Angus W. MacDonald,et al.  Frontal White Matter Integrity as an Endophenotype for Schizophrenia: Diffusion Tensor Imaging in Monozygotic Twins and Patients’ Nonpsychotic Relatives , 2009, Front. Hum. Neurosci..

[16]  M. Kubicki,et al.  Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia , 2009, Human brain mapping.

[17]  Michael H. Buonocore,et al.  Cognitive Control and White Matter Callosal Microstructure in Methamphetamine-Dependent Subjects: A Diffusion Tensor Imaging Study , 2009, Biological Psychiatry.

[18]  C. Man,et al.  'Street ketamine'-associated bladder dysfunction: a report of ten cases. , 2007, Hong Kong medical journal = Xianggang yi xue za zhi.

[19]  K. Jansen Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.

[20]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[21]  Torsten Rohlfing,et al.  Degradation of Association and Projection White Matter Systems in Alcoholism Detected with Quantitative Fiber Tracking , 2009, Biological Psychiatry.

[22]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[23]  Baoci Shan,et al.  Disrupted White Matter Integrity in Heroin Dependence: A Controlled Study Utilizing Diffusion Tensor Imaging , 2008, The American journal of drug and alcohol abuse.

[24]  C. Morgan,et al.  Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. , 2004, Addiction.

[25]  E. Joyce,et al.  Is Persistent Ketamine Use a Valid Model of the Cognitive and Oculomotor Deficits in Schizophrenia? , 2009, Biological Psychiatry.

[26]  E. Domino,et al.  Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man , 1965, Clinical pharmacology and therapeutics.

[27]  In Chan Song,et al.  Decreased frontal white-matter integrity in abstinent methamphetamine abusers. , 2007, The international journal of neuropsychopharmacology.

[28]  Franz X Vollenweider,et al.  A systems model of altered consciousness: integrating natural and drug-induced psychoses , 2001, Brain Research Bulletin.

[29]  E. Nestler Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[30]  Leslie Muetzelfeldt,et al.  Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. , 2010, Addiction.

[31]  Sophia Frangou,et al.  Recent diffusion tensor imaging findings in early stages of schizophrenia , 2009, Current opinion in psychiatry.

[32]  J. Gill,et al.  Ketamine in non-hospital and hospital deaths in New York City. , 2000, Journal of forensic sciences.

[33]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[34]  G. Hunt,et al.  Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong Kong , 2008, Addiction research & theory.

[35]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[36]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[37]  T. Abel,et al.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials , 2009, Neurobiology of Disease.

[38]  Richard S. Ehrlichman,et al.  Ketamine Produces Lasting Disruptions in Encoding of Sensory Stimuli , 2006, Journal of Pharmacology and Experimental Therapeutics.

[39]  D. Charney,et al.  Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression , 2010, Biological Psychiatry.

[40]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[41]  Rita Z. Goldstein,et al.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. , 2002, The American journal of psychiatry.

[42]  Gareth J. Barker,et al.  Diffusion tensor imaging in schizophrenia , 2008, European Psychiatry.

[43]  Erick Jorge Canales-Rodríguez,et al.  Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging , 2010, Molecular Psychiatry.

[44]  J. Krystal,et al.  Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. , 2004, The American journal of psychiatry.

[45]  Tai‐Lung Cha,et al.  Ketamine‐associated bladder dysfunction , 2009, International journal of urology : official journal of the Japanese Urological Association.

[46]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[47]  Adolf Pfefferbaum,et al.  Using Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Brain Damage in Alcoholics , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[48]  G. Ellison The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.

[49]  Paul M. Thompson,et al.  Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine , 2004, The Journal of Neuroscience.

[50]  T. Tonia,et al.  Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). , 2008, Journal of clinical psychopharmacology.